Therefore, in this study, we evaluated the type-I IFN receptor expression in a large panel of available human pancreatic cancer cell lines and associated the receptor expression with the anti-tumour potencies of IFN-α and IFN-β. The gene discussed is IFNB1; the disease is familial pancreatic carcinoma.